Federated Hermes, Inc. Invitae Corp Transaction History

Federated Hermes, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $76 - $324	36 New	36 $1,000
Q4 2020 Feb 12, 2021	SELL	$39.09 - $57.4 $968,611 - $1.42 Million	-24,779 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$28.43 - $44.67 $704,466 - $1.11 Million	24,779 New	24,779 $1.07 Million
Q2 2019 Aug 14, 2019	SELL	$17.37 - $26.27 $13,218 - $19,991	-761 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$10.65 - $25.75 $3,642 - $8,806	342 Added 81.62%	761 $18,000

Q3 2018 Nov 13, 2018	BUY	$7.54 - $18.31 $3,159 - $7,671	419 New	419 $7,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.